The approval of Veklury (remdesivir) was supported by the agency's
analysis of data from three randomized, controlled clinical trials
that included patients hospitalised with mild-to-severe COVID-19, the
FDA said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-approves-use-of-remdesivir-to-treat-covid-19-patients-in-hospitals/articleshow/78821504.cms
No comments:
Post a Comment